Resolution of a neurotrophic keratopathy associated hypopyon with cenegermin

PURPOSE: We present a novel case of a neurotrophic keratopathy associated inflammatory hypopyon that resolved after initiation of therapy with cenegermin (Oxervate; Dompe, Milan, Italy), a recombinant human nerve growth factor (rhNGF). This finding illustrates the potential of cenegermin in advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambino, Nick, Syed, Zeba A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296075/
https://www.ncbi.nlm.nih.gov/pubmed/34307960
http://dx.doi.org/10.1016/j.ajoc.2021.101113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296075/
https://www.ncbi.nlm.nih.gov/pubmed/34307960
http://dx.doi.org/10.1016/j.ajoc.2021.101113

Ejemplares similares